Health outcomes and QOL in paediatric proton therapy

Pursuing the 'elusive' proton CT

When is an assay ready for the clinic?

Building a succesful proton therapy centre

Practical implementation of proton therapy in the UK

The use of proton therapy in relatively new indications

A model-based selection approach to identify suitable indications for proton therapy

IBCD 2016: Patient access and regulatory challenges

Screening Patients for Efficient Clinical Trial Access (SPECTA)

How to avoid false positives in lung cancer

Recent advances and emerging therapies in lung cancer

Developments in gastrointestinal tumour treatment